Munich healthtech company Adon Health, has completed its Pre-Seed financing round. The
amount raised has not been disclosed.
The company was founded in late 2023 by two former McKinsey colleagues, Maximilian Schubert
and Dr Jonathan Apasu.
Adon Health’s product is a vertically integrated platform for complex and underserved therapies,
with a first focus on testosterone replacement therapies.
The platform enables patients to manage their entire care experience digitally and in one place,
making the care experience significantly less complex and time-consuming for the patient.
Backbone Ventures led the funding, alongside the Atomico Angel Programme and several business angels with business-building experience in the European healthcare and consumer ecosystem.
https://tech.eu/2024/04/04/adon-health-completes-pre-seed-funding-for-testosterone-replacement-therapy-platform/
Don't miss out on the excitement! Reserve your spot at WOLVES SUMMIT CEE!
8-9 May 2024, Copernicus Science Centre, Warsaw, Poland + online